Risk assessment in patients with an acute ST-elevation myocardial infarction
- PMID: 27580675
- PMCID: PMC5985500
- DOI: 10.2217/cer-2016-0017
Risk assessment in patients with an acute ST-elevation myocardial infarction
Abstract
ST-elevation myocardial infarction (STEMI) is one of the leading causes of mortality and morbidity worldwide. While the survival after acute STEMI has considerably improved, mortality rate still remains high, especially in high-risk patients. Survival after acute STEMI is influenced by clinical characteristics such as age as well as the presence of comorbidities. However, during emergency care increasing access to tools such as the electrocardiogram, chest x-ray and echocardiography can provide additional information helping to further risk stratify patients. In the invasive setting, this can also include coronary angiography, invasive hemodynamic recordings and angiographic assessments of coronary flow and myocardial perfusion. We outline the common investigations used in STEMI and their role in risk assessment of patients with an acute STEMI.
Keywords: STEMI; cardiac MRI; cardiology/cardiovascular; coronary angiography; echocardiography; evidence-based medicine; invasive hemodynamics; plasma biomarkers; risk assessment; risk scoring.
Conflict of interest statement
C Berry has collaborated with Siemens Healthcare, UK, but without financial gain. This review was supported by a grant from the British Heart Foundation (PG/11/2/28474). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.
Figures


Similar articles
-
Predictors of mortality in patients with non-anterior ST-segment elevation myocardial infarction: Analysis from the HORIZONS-AMI trial.Catheter Cardiovasc Interv. 2019 Aug 1;94(2):172-180. doi: 10.1002/ccd.28096. Epub 2019 Jan 28. Catheter Cardiovasc Interv. 2019. PMID: 30690854 Clinical Trial.
-
Clinical characteristics and outcomes of acute coronary syndrome patients in a PCI-Limited setting: a prospective study from Bhutan.BMC Cardiovasc Disord. 2025 Apr 25;25(1):324. doi: 10.1186/s12872-025-04782-w. BMC Cardiovasc Disord. 2025. PMID: 40281444 Free PMC article.
-
Angiographic characteristics and in-hospital mortality among patients with ST-segment elevation myocardial infarction presenting without typical chest pain: an analysis of China Acute Myocardial Infarction registry.Chin Med J (Engl). 2019 Oct 5;132(19):2286-2291. doi: 10.1097/CM9.0000000000000432. Chin Med J (Engl). 2019. PMID: 31567475 Free PMC article.
-
Contemporary NSTEMI management: the role of the hospitalist.Hosp Pract (1995). 2020 Feb;48(1):1-11. doi: 10.1080/21548331.2020.1701329. Epub 2020 Feb 20. Hosp Pract (1995). 2020. PMID: 31815570 Review.
-
API expert consensus document on management of ischemic heart disease.J Assoc Physicians India. 2006 Jun;54:469-80. J Assoc Physicians India. 2006. PMID: 16909697 Review.
Cited by
-
Cardioprotective Effects of Nicorandil on Coronary Heart Disease Patients Undergoing Elective Percutaneous Coronary Intervention.Med Sci Monit. 2017 Jun 15;23:2924-2930. doi: 10.12659/msm.902324. Med Sci Monit. 2017. PMID: 28617765 Free PMC article. Clinical Trial.
-
Review of Myocardial Ischemia, Scar, and Viability Estimation with Molecular Magnetic Resonance Imaging.Biomedicines. 2024 Jul 27;12(8):1681. doi: 10.3390/biomedicines12081681. Biomedicines. 2024. PMID: 39200146 Free PMC article. Review.
-
Predictive value of novel inflammatory markers combined with GRACE score for in-hospital outcome in patients with ST-segment elevation myocardial infarction: a retrospective observational study.BMJ Open. 2025 Apr 3;15(4):e096621. doi: 10.1136/bmjopen-2024-096621. BMJ Open. 2025. PMID: 40180376 Free PMC article.
-
Advanced Lung Cancer Inflammation Index as Predictor of All-Cause Mortality in ST-Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention.J Clin Med. 2024 Oct 11;13(20):6059. doi: 10.3390/jcm13206059. J Clin Med. 2024. PMID: 39458009 Free PMC article.
-
Influences of different dose of tirofiban for acute ST elevation myocardial infarction patients underwent percutaneous coronary intervention.Medicine (Baltimore). 2020 Jun 5;99(23):e20402. doi: 10.1097/MD.0000000000020402. Medicine (Baltimore). 2020. PMID: 32501985 Free PMC article.
References
-
- Steg G, James SK, Atar D, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology. Eur. Heart J. 2012;22:2569–2619. - PubMed
-
- McManus DD, Gore J, Yarzebski J, Spencer F, Lessard D, Goldberg RJ. Recent trends in the incidence, treatment, and outcomes of patients with STEMI and NSTEMI. Am. J. Med. 2011;124:40–47. - PMC - PubMed
-
• Highlights improvement in incidence, treatment and all-cause outcomes of ST-elevation myocardial infarction patients.
-
- Jernberg T, Johanson P, Held C, Svennblad B, Lindback J, Wallentin L. Association between adoption of evidence-based treatment and survival for patients with ST-elevation myocardial infarction. J. Am. Med. Assoc. 2011;305:1677–1684. - PubMed
-
- Roger VL, Go AS, Lloyd-Jones DM, et al. Executive summary: heart disease and stroke statistics – 2012 update: a report from the American Heart Association. Circulation. 2012;125:188–197. - PubMed
-
- Fox KA, Carruthers KF, Dunbar DR, et al. Underestimated and under-recognized: the late consequences of acute coronary syndrome (GRACE UK-Belgian Study) Eur. Heart J. 2010;31:2755–2764. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical